Inhibitory effects of chloroquine on the activation of plasmacytoid dendritic cells in SIVmac239-infected Chinese rhesus macaques

Cellular and Molecular Immunology

Volumn 9, Issue 5, 2012, Pages 410-416

  Ma, Jian Ping ^a,b   Xia, Hou Jun ^a,b   Zhang, Gao Hong ^a   Han, Jian Bao ^a   Zhang, Li Guo ^c   Zheng, Yong Tang ^a  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c INSTITUTE OF BIOPHYSICS   (China)

Author keywords

Chinese rhesus macaque; chloroquine; immune activation; pDC; SIV

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CHLOROQUINE; GAMMA INTERFERON; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PROTEIN EXPRESSION; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; T LYMPHOCYTE ACTIVATION; VIRUS LOAD;

ANIMALS; CHLOROQUINE; DENDRITIC CELLS; LYMPHOCYTE ACTIVATION; MACACA MULATTA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALIA; MACACA; MACACA MULATTA; PRIMATES; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84866080333     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2012.22     Document Type: Article

References (27)

1. Ketloy C, Engering A, Srichairatanakul U, Limsalakpetch A, Yongvanitchit K, Pichyangkul S et al. Expression and function of Toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates. Vet Immunol Immunopathol 2008; 125: 18-30.
2. John L, Lutwama F. A review of the use of activation markers in Africa. J HIV Ther 2010; 15: 11-14.
3. Mir KD, Gasper MA, Sundaravaradan V, Sodora DL. SIV infection in natural hosts: Resolution of immune activation during the acute-to-chronic transition phase. Microbes Infect 2011; 13: 14-24.
4. Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, Narva'ez AB et al. Immune activation set point during early HIV infection predicts subsequent CD41 T-cell changes independent of viral load. Blood 2004; 104: 942-947.
5. Hazenberg MD, Otto SA, van Benthem BH, Roos MT, Coutinho RA, Lange JM et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003; 17: 1881-1888.
6. Kovacs A, Karim R, Mack WJ, Xu J, Chen Z, Operskalski E et al. Activation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virus. J Infect Dis 2010; 201: 823-834.
7. Chang JJ, Altfeld M. Innate immune activation in primary HIV-1 infection. J Infect Dis 2010; 202 (Suppl 2):S297-S301.
8. Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R. Effects of chloroquine on viral infections: An old drug against today's diseases? Lancet Infect Dis 2003; 11: 722-727.
9. Martinson JA, Montoya CJ, Usuga X, Ronquillo R, Landay AL, Desai SN. Chloroquine modulates HIV-1-induced plasmacytoid dendritic cell alpha interferon: Implication for T-cell activation. Antimicrob Agents Chemother 2010; 54: 871-881.
10. Beignon AS, McKenna K, Skoberne M, Manches O, DaSilva I, Kavanagh DG et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 2005; 11: 3265-3275.
11. Murray SM, Down CM, Boulware DR, Stauffer WM, Cavert WP, Schacker TW et al. Reduction of immune activation with chloroquine therapy during chronic HIV infection. J Virol 2010; 22: 12082-12086.
12. Piconi S, Parisotto S, Rizzardini G, Passerini S, Terzi R, Argenteri B et al. Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders. Blood 2011; 12: 3263-3272.
13. Xia HJ, Zhang GH, Ma JP, Dai ZX, Li SY, Han JB et al. Dendritic cell subsets dynamics and cytokine production in SIVmac239-infected Chinese rhesus macaques. Retrovirology 2010; 7: 102.
14. Xia HJ, Zhang GH, Wang RR, Zheng YT. The influence of age and sex on the cell counts of peripheral blood leukocyte subpopulations in Chinese rhesus macaques. Cell Mol Immunol 2009; 6: 433-440.
15. Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983; 309: 453-458.
16. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S et al. Microbial translocation is a cause of systemic immune. NatMed 2006; 12: 1365-1371.
17. Said EA, Dupuy FP, Trautmann L, Zhang Y, Shi Y, El-FarMet al. Programmed death-1-induced interleukin-10 production by monocytes impairs CD41 T cell activation during HIV infection. Nat Med 2010; 16: 452-459.
18. Colonna M, Trinchieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nat Immunol 2004; 5: 1219-1226.
19. Zhang Z, Wang FS. Plasmacytoid dendritic cells act as the most competent cell type in linking antiviral innate and adaptive immune responses. Cell Mol Immunol 2005; 6: 411-417.
20. Fitzgerald-Bocarsly P, Dai J, Singh S. Plasmacytoid dendritic cells and type I IFN: 50 year of convergent history. Cytokine Growth Factor Rev 2008; 19: 3-19.
21. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 5: 987-995.
22. Xia HJ, Ma JP, Zhang GH, Han JB, Wang JH, Zheng YT. Effect of plasma viremia on apoptosis and immunophenotype of dendritic cells subsets in acute SIVmac239 infection of Chinese rhesus macaques. PLoS ONE 2011; 6: e29036.
23. Herbeuval JP, Shearer GM. HIV-1 immunopathogenesis: how good interferon turns bad. Clin Immunol 2007; 123: 121-128.
24. Meier A, Chang JJ, Chan ES, Pollard RB, Sidhu HK, Kulkarni S et al. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 2009; 8: 955-959.
25. Lehmann C, Harper JM, Taubert D, Hartmann P, Fä tkenheuer G, Jung N et al. Increased interferon alpha expression in circulating plasmacytoid dendritic cells of HIV-1-infected patients. J Acquir Immune Defic Syndr 2008; 48: 522-530.
26. Baenziger S, Heikenwalder M, Johansen P, Schlaepfer E, Hofer U, Miller RC et al. Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology. Blood 2009; 113: 377-388.
27. Jacquelin B, Mayau V, Targat B, Liovat AS, Kunkel D, Petitjean G et al. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest 2009; 12: 3544-3555.